Literature DB >> 1302019

Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11q13.

E M Stone1, B E Nichols, L M Streb, A E Kimura, V C Sheffield.   

Abstract

Macular degeneration is the most common cause of legal blindness in older patients in developed countries. Best's vitelliform dystrophy is an early-onset, autosomal dominant form of macular degeneration characterized by an egg-yolk-like collection of lipofuscin beneath the pigment epithelium of the retinal macula. Fifty-seven members of a five-generation family affected with this disease were studied. A combination of ophthalmoscopy and electro-oculography was used for diagnosis; 29 patients were found to be affected and 16 unaffected. Linkage analysis mapped the disease-causing gene to chromosome 11q13. Three markers in this region were found to be significantly linked (Zmax > 3.0) to the disease. Multipoint analysis yielded a maximum Lod score of 9.3 in the interval between markers INT2 and D11S871.

Entities:  

Mesh:

Year:  1992        PMID: 1302019     DOI: 10.1038/ng0792-246

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  40 in total

1.  A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study.

Authors:  James H Schick; Sudha K Iyengar; Barbara E Klein; Ronald Klein; Karlie Reading; Rachel Liptak; Christopher Millard; Kristine E Lee; Sandra C Tomany; Emily L Moore; Bonnie A Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-04-24       Impact factor: 11.025

2.  Mammalian homolog of Drosophila retinal degeneration B rescues the mutant fly phenotype.

Authors:  J T Chang; S Milligan; Y Li; C E Chew; J Wiggs; N G Copeland; N A Jenkins; P A Campochiaro; D R Hyde; D J Zack
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  Multimodal fundus imaging in Best vitelliform macular dystrophy.

Authors:  Daniela C Ferrara; Rogério A Costa; Stephen Tsang; Daniela Calucci; Rodrigo Jorge; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

4.  A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.

Authors:  S C Guru; S K Agarwal; P Manickam; S E Olufemi; J S Crabtree; J M Weisemann; M B Kester; Y S Kim; Y Wang; M R Emmert-Buck; L A Liotta; A M Spiegel; M S Boguski; B A Roe; F S Collins; S J Marx; L Burns; S C Chandrasekharappa
Journal:  Genome Res       Date:  1997-07       Impact factor: 9.043

5.  Still no evidence for heterogeneity in Best's vitelliform macular dystrophy.

Authors:  C Graff; C Wadelius
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

Review 6.  Gene-based approach to human gene-phenotype correlations.

Authors:  T P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

7.  The mouse homologs of RELA and MLK3 are located within a 120-kb fragment on chromosome 19.

Authors:  M Fernandes; C Poirier; N J Lassam; C Larsson; J Guénet; P Gaudray; G F Carle
Journal:  Mamm Genome       Date:  1997-07       Impact factor: 2.957

Review 8.  Molecular genetics of macular dystrophies.

Authors:  K Zhang; H Yeon; M Han; L A Donoso
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

9.  Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene.

Authors:  J T Pang; S E Lloyd; C Wooding; B Farren; B Pottinger; B Harding; S E Leigh; M A Pook; F J Benham; G T Gillett; R T Taggart; R V Thakker
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

10.  Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene.

Authors:  Giuseppe Querques; Jennyfer Zerbib; Rossana Santacroce; Maurizio Margaglione; Nathalie Delphin; Jean-Michel Rozet; Josseline Kaplan; Domenico Martinelli; Nicola Delle Noci; Gisèle Soubrane; Eric H Souied
Journal:  Mol Vis       Date:  2009-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.